Cargando…
COVID-19 and the burning issue of drug interaction: never forget the ECG
The coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), has been rapidly escalating, becoming a relevant threat to global health. Being a recent virus outbreak, there are still no available therapeutic regimens that have been approved in lar...
Autores principales: | Sciaccaluga, Carlotta, Cameli, Matteo, Menci, Daniele, Mandoli, Giulia Elena, Sisti, Nicolò, Cameli, Paolo, Franchi, Federico, Mondillo, Sergio, Valente, Serafina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016843/ https://www.ncbi.nlm.nih.gov/pubmed/32820084 http://dx.doi.org/10.1136/postgradmedj-2020-138093 |
Ejemplares similares
-
COVID-19 in patients with heart failure: the new and the old epidemic
por: Sisti, Nicolò, et al.
Publicado: (2020) -
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge
por: Sisti, Nicolò, et al.
Publicado: (2021) -
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence
por: Sciaccaluga, Carlotta, et al.
Publicado: (2022) -
Heart transplantation and anti‐HLA antibodY: myocardial dysfunction and prognosis ‐ HeartLAy study
por: Sciaccaluga, Carlotta, et al.
Publicado: (2023) -
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications
por: Cameli, Matteo, et al.
Publicado: (2021)